FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David McGuinn

Research Profile

Living Beings

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Shakun M Malik; Ke Liu; Xu Qiang; R Sridhara; Shenghui Tang; W David McGuinn; S Leigh Verbois; Anshu Marathe; Gene M Williams; Julie Bullock; Christoffer Tornoe; Sue Ching Lin; Terrance Ocheltree; Milinda Vialpando; Alice Kacuba; Robert Justice; Richard Pazdur
Folotyn (pralatrexate injection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summary.
Hans Rosenfeldt; Timothy Kropp; Kimberly Benson; M Stacey Ricci; W David McGuinn; S Leigh Verbois
Regulatory aspects of oncology drug safety evaluation: past practice, current issues, and the challenge of new drugs.
Robert C Kane; W David McGuinn; Ramzi Dagher; Robert Justice; Richard Pazdur
Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David McGuinn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Shakun M Malik; Ke Liu; Xu Qiang; R Sridhara; Shenghui Tang; W David McGuinn; S Leigh Verbois; Anshu Marathe; Gene M Williams; Julie Bullock; Christoffer Tornoe; Sue Ching Lin; Terrance Ocheltree; Milinda Vialpando; Alice Kacuba; Robert Justice; Richard Pazdur
Folotyn (pralatrexate injection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summary.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(20):4921-7.
2010: Hans Rosenfeldt; Timothy Kropp; Kimberly Benson; M Stacey Ricci; W David McGuinn; S Leigh Verbois
Regulatory aspects of oncology drug safety evaluation: past practice, current issues, and the challenge of new drugs.
Toxicology and applied pharmacology 2010;243(2):125-33.
2008: Robert C Kane; W David McGuinn; Ramzi Dagher; Robert Justice; Richard Pazdur
Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.
The oncologist 2008;13(4):445-50.
2006: Martin H Cohen; John R Johnson; Tristan Massie; R Sridhara; W David McGuinn; Sophia Abraham; Brian P Booth; M Anwar Goheer; David Morse; Xiao H Chen; Nallaperumal Chidambaram; Leslie Kenna; Jogarao V S Gobburu; Robert Justice; Richard Pazdur
Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5329-35.
2005: Thomas M Badger; Mats Hidestrand; Kartik Shankar; W David McGuinn; Martin J J Ronis
The effects of pregnancy on ethanol clearance.
Life sciences 2005;77(17):2111-26.
2004: Peter F Bross; Robert Kane; Ann T Farrell; Sophia Abraham; Kimberly Benson; Margaret E Brower; Sean Bradley; Jogarao V S Gobburu; Anwar Goheer; Shwu-Luan Lee; John Leighton; Cheng Yi Liang; Richard T Lostritto; W David McGuinn; David E Morse; Atiqur Rahman; Lilliam A Rosario; S Leigh Verbois; Grant Williams; Yong-Cheng Wang; Richard Pazdur
Approval summary for bortezomib for injection in the treatment of multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):3954-64.
2004: Martin H Cohen; Grant A Williams; R Sridhara; Gang Chen; W David McGuinn; David Morse; Sophia Abraham; Atiqur Rahman; Chenyi Liang; Richard T Lostritto; Amy Baird; Richard Pazdur
United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1212-8.
2004: Ilona Petrikovics; D Papahadjopoulos; K Hong; Tu-Chen Cheng; Steven I Baskin; Jing Jiang; JC Jaszberenyi; B A Logue; M Szilasi; W David McGuinn; JL Way
Comparing therapeutic and prophylactic protection against the lethal effect of paraoxon.
Toxicological sciences : an official journal of the Society of Toxicology 2004;77(2):258-62.
2000: Ilona Petrikovics; Tu-Chen Cheng; D Papahadjopoulos; K Hong; R Yin; Joseph J DeFrank; J Jaing; Z H Song; W David McGuinn; D Sylvester; L Pei; J Madec; C Tamulinas; JC Jaszberenyi; T Barcza; JL Way
Long circulating liposomes encapsulating organophosphorus acid anhydrolase in diisopropylfluorophosphate antagonism.
Toxicological sciences : an official journal of the Society of Toxicology 2000;57(1):16-21.
2000: Ilona Petrikovics; W David McGuinn; D Sylvester; P Yuzapavik; Jing Jiang; JL Way; D Papahadjopoulos; K Hong; R Yin; Tu-Chen Cheng; Joseph J DeFrank
In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism.
Drug delivery 2000;7(2):83-9.
1999: Ilona Petrikovics; K Hong; G Omburo; Q Z Hu; L Pei; W David McGuinn; D Sylvester; C Tamulinas; D Papahadjopoulos; JC Jaszberenyi; JL Way
Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes.
Toxicology and applied pharmacology 1999;156(1):56-63.
1998: JJ DeGeorge; C H Ahn; P A Andrews; Margaret E Brower; D W Giorgio; M A Goheer; D Y Lee-Ham; W David McGuinn; W Schmidt; C J Sun; S C Tripathi
Regulatory considerations for preclinical development of anticancer drugs.
Cancer chemotherapy and pharmacology 1998;41(3):173-85.
1997: JJ DeGeorge; C H Ahn; P A Andrews; Margaret E Brower; Y S Choi; M Y Chun; T Du; D Y Lee-Ham; W David McGuinn; L Pei; L F Sancilio; W Schmidt; H V Sheevers; C J Sun; S Tripathi; W Mark Vogel; V Whitehurst; S Williams; A S Taylor
Considerations for toxicology studies of respiratory drug products.
Regulatory toxicology and pharmacology : RTP 1997;25(2):189-93.
1995: I Petrikovics; E P Cannon; W David McGuinn; L Pei; L Pu; L E Lindner; J L Way
Cyanide antagonism with carrier erythrocytes and organic thiosulfonates.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1995;24(1):86-93.
1994: L Pei; W David McGuinn; G Omburo; A H Zitzer; I Petrikovics; J L Way
Spectrophotometric determination of paraoxonase within mouse carrier red blood cells.
Biotechnology and applied biochemistry 1994;20 ( Pt 1)():35-41.
1994: W David McGuinn; L Baxter; L Pei; I Petrikovics; E P Cannon; J L Way
Antagonism of the lethal effects of cyanide by a synthetic water-soluble cobalt(III) porphyrin compound.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1994;23(1):76-80.
1994: I Petrikovics; L Pei; W David McGuinn; E P Cannon; J L Way
Encapsulation of rhodanese and organic thiosulfonates by mouse erythrocytes.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1994;23(1):70-5.
1994: L Pei; G Omburo; W David McGuinn; I Petrikovics; K Dave; Frank M Raushel; James R Wild; J R DeLoach; J L Way
Encapsulation of phosphotriesterase within murine erythrocytes.
Toxicology and applied pharmacology 1994;124(2):296-301.
1993: W David McGuinn; E P Cannon; C T Chui; L Pei; I Petrikovics; J L Way
The encapsulation of squid diisopropylphosphorofluoridate-hydrolyzing enzyme within mouse erythrocytes.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1993;21(1):38-43.